// App-Quantinova.ai

2561 : Imbalances of Chromosome 21 in MDS/AML Include Cryptic Deletions but NOT RUNX1 Amplifications.

Researchers

Presenter

  • Diana Brazma

Principal Investigators

  • Nahid Zarein

  • Julie Howard-Reeves

  • Phaidra Partheniou

  • Colin Grace

  • Elisabeth P. Nacheva

Medical Centers

  • Academic Haematology, Molecular Cytogenetics Laboratory, UCL Med School, Royal Free Campus, London, United Kingdom,

  • Academic Haematology, UCL Medical School, Royal Free Campus, London, United Kingdom

  • Academic Haematology, Molecular Cytogenetics Laboratory, UCL Med School, Royal Free Campus, London, United Kingdom,

  • Academic Haematology, Molecular Cytogenetics Laboratory, UCL Med School, Royal Free Campus, London, United Kingdom,

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Acute lymphoblastic leukemia

  • Myelodysplastic Syndrome

  • Acute myelocytic leukemia

  • Down syndrome

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • ETS transcription factor ERG

  • ETV6-RUNX1

  • Telomerase reverse transcriptase

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved